SMARCB1 / INI1 ‐deficient intrathoracic neoplasm with rhabdoid/plasmacytoid cytomorphology in a patient with plasma cell myeloma: A case report
Diagnostic Cytopathology · 2023-10 · 51 (10)
DOI: 10.1002/dc.25197 ↗At a glance
Fallbericht in Diagnostic Cytopathology, published online on 2023-07-20. Written by Kazuki Fujita and 10 co-authors. Institution: Department of Diagnostic Pathology, Kanazawa University Hospital, Kanazawa, Japan. Major MEDLINE topics: Multiple Myeloma, Rhabdoid Tumor. Cited 3 times so far (Crossref); 16 references. The full text is freely available (open access, CC BY 4.0).
Abstract (original language)
SMARCB1 (INI1) is one of the switch/sucrose nonfermentable (SWI/SNF) complexes whose loss is associated with several tumors. SMARCB1 (INI1)‐deficient intrathoracic neoplasms are extremely rare and known to be highly malignant and lethal. This report presents the case of a patient diagnosed with SMARCB1 (INI1)‐deficient intrathoracic neoplasm during chemotherapy for plasma cell myeloma. A 77‐year‐old male patient complained of cough, bloody sputum, and fever with an enlarged right lung mass and pleural effusion. His cytological examination revealed undifferentiated epithelioid and rhabdoid/plasmacytoid cells with bi‐ or multinucleation, vacuolization, mitosis, and pleomorphism. However, it was difficult to distinguish the relapse of plasma cell myeloma as atypical plasmacytoid cells were detected. Immunohistochemically, the neoplastic cells showed a loss of SMARCB1 (INI1) expression in the cell block of pleural fluid and in the right lung of the autopsy specimen. Further, the patient was diagnosed with SMARCB1 (INI1)‐deficient intrathoracic neoplasm of the right lung based on histological and autopsy findings. To the best of our knowledge, this is the first report of cytomorphology in a SMARCB1 (INI1)‐deficient intrathoracic neoplasm.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Diagnostic Pathology, Kanazawa University Hospital, Kanazawa, Japan.
- Department of Hematology, Kanazawa University Hospital, Kanazawa, Japan.
ORCID profiles: Hiroko Ikeda
Cite
APA
Fujita, K., Mizuguchi, K., Mori, T., Shimoda, T., Sakano, K., Shimaguchi, C., Ito, A., Yoshimura, K., Sakaguchi, M., Imi, T., & Ikeda, H. (2023). SMARCB1 / INI1 ‐deficient intrathoracic neoplasm with rhabdoid/plasmacytoid cytomorphology in a patient with plasma cell myeloma: A case report. Diagnostic Cytopathology, 51(10). https://doi.org/10.1002/dc.25197
Vancouver
Fujita K, Mizuguchi K, Mori T, Shimoda T, Sakano K, Shimaguchi C, et al. SMARCB1 / INI1 ‐deficient intrathoracic neoplasm with rhabdoid/plasmacytoid cytomorphology in a patient with plasma cell myeloma: A case report. Diagnostic Cytopathology. 2023;51(10). doi:10.1002/dc.25197
BibTeX
@article{Fujita2023,
author = {Fujita, Kazuki and Mizuguchi, Keishi and Mori, Tatsuya and Shimoda, Tsubasa and Sakano, Kaori and Shimaguchi, Chie and Ito, Ayumi and Yoshimura, Kaori and Sakaguchi, Maki and Imi, Tatsuya and Ikeda, Hiroko},
title = {SMARCB1 / INI1 ‐deficient intrathoracic neoplasm with rhabdoid/plasmacytoid cytomorphology in a patient with plasma cell myeloma: A case report},
journal = {Diagnostic Cytopathology},
year = {2023},
volume = {51},
number = {10},
doi = {10.1002/dc.25197}
}
EUVIMED